{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T08:28:12Z","timestamp":1771057692356,"version":"3.50.1"},"reference-count":148,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.ecl.2011.01.007","type":"journal-article","created":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T12:12:46Z","timestamp":1305202366000},"page":"343-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Familial or Genetic Primary Aldosteronism and Gordon Syndrome"],"prefix":"10.1016","volume":"40","author":[{"given":"Michael","family":"Stowasser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Pimenta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2011.01.007_bib1","first-page":"257","article-title":"The evolution of primary aldosteronism: 1954\u20131967","volume":"62","author":"Conn","year":"1966","journal-title":"Harvey Lect"},{"key":"10.1016\/j.ecl.2011.01.007_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0140-6736(92)93225-C","article-title":"Primary aldosteronism: hypertension with a genetic basis","volume":"340","author":"Gordon","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2011.01.007_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ecl.2011.01.007_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.jhh.1001013","article-title":"High prevalence of primary aldosteronism in the Tayside hypertension clinic population","volume":"14","author":"Lim","year":"2000","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.ecl.2011.01.007_bib5","first-page":"2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore","volume":"85","author":"Loh","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib6","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib7","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A\u00a0prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ecl.2011.01.007_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00019616-199707040-00003","article-title":"Primary aldosteronism: update on diagnosis and treatment","volume":"7","author":"Young","year":"1997","journal-title":"Endocrinologist"},{"key":"10.1016\/j.ecl.2011.01.007_bib9","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mce.2003.10.006","article-title":"Primary aldosteronism\u2013careful investigation is essential and rewarding","volume":"217","author":"Stowasser","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ecl.2011.01.007_bib11","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/archsurg.1996.01430180072015","article-title":"Factors influencing outcome of surgery for primary aldosteronism","volume":"131","author":"Celen","year":"1996","journal-title":"Arch Surg"},{"key":"10.1016\/j.ecl.2011.01.007_bib12","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s002689900552","article-title":"Success of surgery for primary aldosteronism judged by residual autonomous aldosterone production","volume":"22","author":"Rutherford","year":"1998","journal-title":"World J Surg"},{"key":"10.1016\/j.ecl.2011.01.007_bib13","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/00004872-200311000-00025","article-title":"High rate of detection of primary aldosteronism, including surgically treatable forms, after \u2018non-selective\u2019 screening of hypertensive patients","volume":"21","author":"Stowasser","year":"2003","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2011.01.007_bib14","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2009-1763","article-title":"Improved quality of life, blood pressure, and biochemical status following unilateral laparoscopic adrenalectomy for unilateral primary aldosteronism","volume":"95","author":"Sukor","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00004872-200103000-00001","article-title":"A\u00a0review of the medical treatment of primary aldosteronism","volume":"19","author":"Lim","year":"2001","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2011.01.007_bib16","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1210\/jc.2008-2803","article-title":"Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience","volume":"94","author":"Sukor","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib17","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ecl.2011.01.007_bib18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"Renal damage in primary aldosteronism: results of the PAPY Study","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2011.01.007_bib19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0895-7061(02)03021-2","article-title":"Left ventricular changes in primary aldosteronism","volume":"16","author":"Rossi","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ecl.2011.01.007_bib20","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system","volume":"83","author":"Weber","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2011.01.007_bib21","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/00004872-200208000-00002","article-title":"Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system","volume":"20","author":"Young","year":"2002","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2011.01.007_bib22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ecl.2011.01.007_bib23","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0300-595X(85)80078-5","article-title":"Histopathology of the human adrenal cortex","volume":"14","author":"Neville","year":"1985","journal-title":"Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1210\/jcem-73-2-281","article-title":"Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds","volume":"73","author":"Skogseid","year":"1991","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib25","first-page":"564","article-title":"Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus","volume":"75","author":"Beckers","year":"1992","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2011.01.007_bib27","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","article-title":"Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample","volume":"49","author":"Newton-Cheh","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2011.01.007_bib28","first-page":"1109","article-title":"Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone","volume":"95","author":"Sutherland","year":"1966","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.ecl.2011.01.007_bib29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2265.1985.tb00168.x","article-title":"A\u00a0new family with dexamethasone-suppressible hyperaldosteronism: aldosterone unresponsiveness to angiotensin II","volume":"22","author":"Fallo","year":"1985","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2011.01.007_bib30","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jcem.85.9.6834","article-title":"Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension","volume":"85","author":"Stowasser","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib31","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A\u00a0chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ecl.2011.01.007_bib32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ng0992-66","article-title":"Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase","volume":"2","author":"Lifton","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/j.ecl.2011.01.007_bib33","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1172\/JCI118279","article-title":"Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree","volume":"96","author":"Pascoe","year":"1995","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ecl.2011.01.007_bib34","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1210\/jcem-59-5-1022","article-title":"Elevated urinary excretion of 18-oxocortisol in glucocorticoid-suppressible aldosteronism","volume":"59","author":"Gomez-Sanchez","year":"1984","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1440-1681.1996.tb02789.x","article-title":"Production of 18-oxo-cortisol in\u00a0subtypes of primary aldosteronism","volume":"23","author":"Stowasser","year":"1996","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ecl.2011.01.007_bib36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.7326\/0003-4819-116-10-813","article-title":"Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype","volume":"116","author":"Rich","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ecl.2011.01.007_bib37","first-page":"2160","article-title":"Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance","volume":"85","author":"Stowasser","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.jhh.1001636","article-title":"Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism","volume":"18","author":"Fallo","year":"2004","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.ecl.2011.01.007_bib39","first-page":"4031","article-title":"Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I","volume":"84","author":"Stowasser","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib40","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1006\/bbrc.1995.1225","article-title":"A\u00a0new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension","volume":"207","author":"Jonsson","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ecl.2011.01.007_bib41","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1210\/jcem.83.7.4946","article-title":"Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene","volume":"83","author":"Mulatero","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib42","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib43","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1161\/HYPERTENSIONAHA.108.128512","article-title":"Elevated serum interleukin 6 levels in normotensive individuals with familial hyperaldosteronism type 1","volume":"53","author":"Staermose","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2011.01.007_bib44","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1681.1991.tb01446.x","article-title":"Clinical and pathological diversity of primary aldosteronism, including a new familial variety","volume":"18","author":"Gordon","year":"1991","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ecl.2011.01.007_bib45","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/pgmj.68.806.976","article-title":"Familial Conn\u2019s syndrome","volume":"68","author":"London","year":"1992","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ecl.2011.01.007_bib46","first-page":"159","article-title":"Genetic studies in familial aldosteronism not suppressible by dexamethasone","volume":"1","author":"Fallo","year":"2000","journal-title":"J\u00a0Endocr Genet"},{"key":"10.1016\/j.ecl.2011.01.007_bib47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1440-1681.1992.tb00462.x","article-title":"Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism","volume":"19","author":"Stowasser","year":"1992","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ecl.2011.01.007_bib48","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0960-0760(01)00097-8","article-title":"Familial hyperaldosteronism","volume":"78","author":"Stowasser","year":"2001","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ecl.2011.01.007_bib49","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1043-2760(03)00112-7","article-title":"Primary aldosteronism: from genesis to genetics","volume":"14","author":"Stowasser","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib50","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1043-2760(98)00058-7","article-title":"Familial forms broaden horizons in primary aldosteronism","volume":"9","author":"Gordon","year":"1998","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nsb0197-32","article-title":"The amino acid substitutions Ser288Gly and Val320Ala convert the cortisol producing enzyme, CYP11B1, into an aldosterone producing enzyme","volume":"4","author":"Curnow","year":"1997","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.ecl.2011.01.007_bib52","first-page":"4228","article-title":"Mutations in CYP11B1 gene converting 11beta-hydroxylase into an aldosterone-producing enzyme are not present in aldosterone-producing adenomas","volume":"84","author":"Pilon","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib53","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1440-1681.1996.tb02786.x","article-title":"PCR-SSCP analysis of the p53 gene in tumours of the adrenal gland","volume":"23","author":"Ballantine","year":"1996","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ecl.2011.01.007_bib54","first-page":"3214","article-title":"Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene","volume":"83","author":"Torpy","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib55","first-page":"1046","article-title":"Linkage analysis of familial hyperaldosteronism type II\u2013absence of linkage to the gene encoding the angiotensin II receptor type 1","volume":"83","author":"Torpy","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib56","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/jmg.37.11.831","article-title":"A\u00a0novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22)","volume":"37","author":"Lafferty","year":"2000","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.ecl.2011.01.007_bib57","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/01.hjh.0000174299.66369.26","article-title":"Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity","volume":"23","author":"So","year":"2005","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2011.01.007_bib58","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1097\/HJH.0b013e3283028352","article-title":"Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families","volume":"26","author":"Sukor","year":"2008","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2011.01.007_bib59","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.jhh.1001747","article-title":"Retention of heterozygosity at chromosome 7p22\u00a0and 11q13 in aldosterone-producing tumours of patients with familial hyperaldosteronism not remediable by glucocorticoids","volume":"18","author":"Fallo","year":"2004","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.ecl.2011.01.007_bib60","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1365-2265.2004.02155.x","article-title":"Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: no evidence for mutations in familial hyperaldosteronism type II in a large affected kindred","volume":"61","author":"Elphinstone","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2011.01.007_bib61","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1440-1681.2008.04882.x","article-title":"Examination of chromosome 7p22 candidate genes RBaK, PMS2 and GNA12 in familial hyperaldosteronism type II","volume":"35","author":"Jeske","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ecl.2011.01.007_bib62","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1365-2265.2006.02674.x","article-title":"No evidence for coding region mutations in the retinoblastoma-associated Kruppel-associated box protein gene (RBaK) causing familial hyperaldosteronism type II","volume":"65","author":"So","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2011.01.007_bib63","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00000441-200112000-00002","article-title":"Liddle syndrome: genetics and mechanisms of Na+ channel defects","volume":"322","author":"Warnock","year":"2001","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ecl.2011.01.007_bib64","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.pharmthera.2004.11.010","article-title":"WNK kinases and the control of blood pressure","volume":"106","author":"Cope","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ecl.2011.01.007_bib65","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","article-title":"A\u00a0novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism","volume":"93","author":"Geller","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib66","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ecl.2011.01.007_bib67","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1210\/jc.2008-1241","article-title":"A\u00a0new form of hereditary primary aldosteronism: familial hyperaldosteronism type III","volume":"93","author":"Mulatero","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib68","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1055\/s-0029-1246187","article-title":"Familial hyperaldosteronism I-III","volume":"42","author":"Quack","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ecl.2011.01.007_bib69","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/00004872-200018090-00002","article-title":"Primary aldosteronism: learning from the study of familial varieties","volume":"18","author":"Stowasser","year":"2000","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2011.01.007_bib70","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1210\/jcem-55-5-1013","article-title":"Familial hyperaldosteronism, not suppressed by dexamethasone","volume":"55","author":"Greco","year":"1982","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib71","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00467-003-1339-2","article-title":"Non-glucocorticoid-remediable aldosteronism in an infant with low-renin hypertension","volume":"19","author":"Malagon-Rogers","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ecl.2011.01.007_bib72","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/01.HYP.33.2.703","article-title":"Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2","volume":"33","author":"Davies","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2011.01.007_bib73","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1210\/jc.2001-012070","article-title":"Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio","volume":"87","author":"Lim","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib74","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1046\/j.1365-2265.2001.01287.x","article-title":"Polymorphic differences from normal in the aldosterone synthase gene (CYP11B2) in patients with primary hyperaldosteronism and adrenal tumour (Conn\u2019s syndrome)","volume":"54","author":"Inglis","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2011.01.007_bib75","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1210\/jc.2002-021598","article-title":"A\u00a0biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to renin ratio in selected hypertensive patients","volume":"88","author":"Nicod","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib76","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.HYP.35.3.699","article-title":"Lys(173)Arg and -344T\/C variants of CYP11B2 in Japanese patients with low-renin hypertension","volume":"35","author":"Komiya","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2011.01.007_bib77","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/01.HYP.35.3.694","article-title":"CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism","volume":"35","author":"Mulatero","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2011.01.007_bib78","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0895-7061(98)00048-X","article-title":"Genetic determination of plasma aldosterone levels in essential hypertension","volume":"11","author":"Pojoga","year":"1998","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ecl.2011.01.007_bib79","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/er.2007-0030","article-title":"A\u00a0lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function","volume":"29","author":"Connell","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2011.01.007_bib80","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1046\/j.1365-2265.2001.01264.x","article-title":"An influence of variation in the aldosterone synthase gene (CYP11B2) on corticosteroid responses to ACTH in normal human subjects","volume":"54","author":"Davies","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2011.01.007_bib81","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1365-2265.2006.02673.x","article-title":"Functional effects of genetic variants in the 11beta-hydroxylase (CYP11B1) gene","volume":"65","author":"Barr","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2011.01.007_bib82","first-page":"4310","article-title":"Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications","volume":"81","author":"Carroll","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib83","first-page":"1633","article-title":"Genetic analysis of aldosterone synthase in patients with idiopathic hyperaldosteronism","volume":"84","author":"Takeda","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib84","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3109\/07435809809032702","article-title":"Aldosterone synthase gene in patients suffering from hyperaldosteronism","volume":"24","author":"Hampf","year":"1998","journal-title":"Endocr Res"},{"key":"10.1016\/j.ecl.2011.01.007_bib85","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1440-1681.1995.tb02043.x","article-title":"PCR-SSCP analysis of the angiotensin II type 1 receptor gene in patients with aldosterone-producing adenomas","volume":"22","author":"Klemm","year":"1995","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ecl.2011.01.007_bib86","first-page":"611","article-title":"Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone-producing adenoma","volume":"82","author":"Davies","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib87","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/gcc.2870120114","article-title":"Allelic losses on chromosome band 11q13 in aldosterone-producing adrenal tumors","volume":"12","author":"Iida","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ecl.2011.01.007_bib88","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1440-1681.1996.tb02790.x","article-title":"Different allelic patterns at chromosome 11q13 in paired aldosterone-producing tumours and blood DNA","volume":"23","author":"Gordon","year":"1996","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ecl.2011.01.007_bib89","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.yjmcc.2009.08.005","article-title":"Delayed rectifier K(+) currents and cardiac repolarization","volume":"48","author":"Charpentier","year":"2010","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.ecl.2011.01.007_bib90","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/01.RES.80.2.261","article-title":"Tissue and species distribution of mRNA for the IKr-like K+ channel, erg","volume":"80","author":"Wymore","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/j.ecl.2011.01.007_bib91","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/01.hjh.0000209984.28735.fd","article-title":"The functional HERG variant 897T is associated with Conn\u2019s adenoma","volume":"24","author":"Sarzani","year":"2006","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2011.01.007_bib92","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1161\/HYPERTENSIONAHA.110.150318","article-title":"Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro","volume":"55","author":"Williams","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2011.01.007_bib93","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1210\/jc.2008-1131","article-title":"Expression and functional role of urotensin-II and its receptor in the adrenal cortex and medulla: novel insights for the pathophysiology of primary aldosteronism","volume":"94","author":"Giuliani","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib94","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1172\/JCI28764","article-title":"Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice","volume":"117","author":"Billet","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ecl.2011.01.007_bib95","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/01.CIR.0000156448.74296.FE","article-title":"Elevated blood pressure linked to primary hyperaldosteronism and impaired vasodilation in BK channel-deficient mice","volume":"112","author":"Sausbier","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2011.01.007_bib96","doi-asserted-by":"crossref","first-page":"11800","DOI":"10.1073\/pnas.0904635106","article-title":"Hypertension of Kcnmb1-\/- is linked to deficient K secretion and aldosteronism","volume":"106","author":"Grimm","year":"2009","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ecl.2011.01.007_bib97","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1073\/pnas.0811706106","article-title":"An adrenal beta-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo","volume":"106","author":"Lymperopoulos","year":"2009","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ecl.2011.01.007_bib98","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nm.2061","article-title":"Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6","volume":"16","author":"Doi","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.ecl.2011.01.007_bib99","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1073\/pnas.0712000105","article-title":"TASK channel deletion in mice causes primary hyperaldosteronism","volume":"105","author":"Davies","year":"2008","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ecl.2011.01.007_bib100","doi-asserted-by":"crossref","first-page":"R571","DOI":"10.1152\/ajpregu.00070.2009","article-title":"Hyperaldosteronism, hypervolemia, and increased blood pressure in mice expressing defective APC","volume":"297","author":"Bhandaru","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.ecl.2011.01.007_bib101","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/HYPERTENSIONAHA.107.098897","article-title":"Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase","volume":"51","author":"Makhanova","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2011.01.007_bib102","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5694\/j.1326-5377.1964.tb115766.x","article-title":"Hypertension and hyperpotassaemia without renal disease in a young male","volume":"2","author":"Paver","year":"1964","journal-title":"Med J Aust"},{"key":"10.1016\/j.ecl.2011.01.007_bib103","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0002-9343(69)90230-7","article-title":"Hyperkalemia, hypertension and systemic acidosis without renal failure associated with a tubular defect in potassium excretion","volume":"47","author":"Arnold","year":"1969","journal-title":"Am J Med"},{"key":"10.1016\/j.ecl.2011.01.007_bib104","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/imj.1970.19.4.287","article-title":"Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction","volume":"4","author":"Gordon","year":"1970","journal-title":"Australas Ann Med"},{"key":"10.1016\/j.ecl.2011.01.007_bib105","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0002-9343(62)90214-0","article-title":"Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis: a new syndrome","volume":"33","author":"Barrter","year":"1962","journal-title":"Am J Med"},{"key":"10.1016\/j.ecl.2011.01.007_bib106","first-page":"249","article-title":"Studies on the efferent mechanism of the sodium diuresis which follows the administration of intravenous saline in the dog","volume":"21","author":"de Wardener","year":"1961","journal-title":"Clin Sci"},{"key":"10.1016\/j.ecl.2011.01.007_bib107","series-title":"The kidney: an outline of normal and abnormal structure and function","first-page":"230","article-title":"Selective defects of tubular function","author":"de Wardener","year":"1973"},{"key":"10.1016\/j.ecl.2011.01.007_bib108","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0024-3205(81)90370-2","article-title":"A\u00a0rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats","volume":"28","author":"DeBold","year":"1981","journal-title":"Life Sci"},{"key":"10.1016\/j.ecl.2011.01.007_bib109","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0140-6736(86)90805-6","article-title":"Plasma atrial natriuretic peptide in primary aldosteronism (before and after treatment) and in Bartter\u2019s and Gordon\u2019s syndromes","volume":"1","author":"Tunny","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2011.01.007_bib110","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1440-1681.1986.tb00360.x","article-title":"Plasma levels of atrial natriuretic peptide in man in primary aldosteronism, in Gordon\u2019s syndrome and in Bartter\u2019s syndrome","volume":"13","author":"Tunny","year":"1986","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ecl.2011.01.007_bib111","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJM198608143150716","article-title":"Indomethacin and atrial natriuretic peptide in Barrter\u2019s syndrome","volume":"315","author":"Gordon","year":"1986","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2011.01.007_bib112","first-page":"331","article-title":"A\u00a0deficient response of atrial natriuretic peptide to volume overload in Gordon\u2019s syndrome","volume":"120","author":"Valimaki","year":"1989","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"Suppl 4","key":"10.1016\/j.ecl.2011.01.007_bib113","doi-asserted-by":"crossref","first-page":"s323","DOI":"10.1097\/00004872-198812040-00100","article-title":"A\u00a0new Australian kindred with the syndrome of hypertension and hyperkalemia has dysregulation of atrial natriuretic factor","volume":"8","author":"Gordon","year":"1988","journal-title":"J\u00a0Hypertens"},{"issue":"Spec No","key":"10.1016\/j.ecl.2011.01.007_bib114","first-page":"193","volume":"81","author":"Ader","year":"1988","journal-title":"Arch Mal Coeur Vaiss"},{"key":"10.1016\/j.ecl.2011.01.007_bib115","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF00849256","article-title":"The syndrome of hypertension and hyperkalaemia with normal glomerular function (Gordon\u2019s syndrome). A pathophysiological study","volume":"1","author":"Semmekrot","year":"1987","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ecl.2011.01.007_bib116","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0161-4630(80)90042-7","article-title":"Etiological considerations in Gordon\u2019s syndrome: possible role of prostaglandins","volume":"4","author":"Tormey","year":"1980","journal-title":"Prostaglandins Med"},{"key":"10.1016\/j.ecl.2011.01.007_bib117","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/00004872-200018090-00019","article-title":"Gordon\u2019s syndrome: increased maximal rate of the Na-K-Cl cotransport and erythrocyte membrane replacement of sphingomyelin by phosphatidylethanolamine","volume":"18","author":"Stiefel","year":"2000","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2011.01.007_bib118","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1001\/archinte.1978.03630370042020","article-title":"Familial hyperpotassemia and hypertension accompanied by normal plasma aldosterone levels: possible cell membrane defect","volume":"138","author":"Farfel","year":"1978","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ecl.2011.01.007_bib119","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1097\/00004872-200111000-00005","article-title":"Genetic heterogeneity of familial hyperkalaemic hypertension","volume":"19","author":"Disse-Nicodeme","year":"2001","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2011.01.007_bib120","series-title":"Handbook of hypertension, vol. 15 (Robertson JIS, editor. Clinical hypertension.)","first-page":"461","article-title":"Gordon's syndrome and Liddle's syndrome","author":"Gordon","year":"1992"},{"key":"10.1016\/j.ecl.2011.01.007_bib121","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/01.HYP.8.2.93","article-title":"Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate","volume":"8","author":"Gordon","year":"1986","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2011.01.007_bib122","series-title":"Hypertension: pathophysiology, diagnosis and management","first-page":"1625","article-title":"The syndrome of hypertension with hyperkalemia and normal glomerular filtration rate. A rare form of hypertension","author":"Gordon","year":"1990"},{"key":"10.1016\/j.ecl.2011.01.007_bib123","series-title":"Hypertension: pathophysiology, diagnosis and treatment","first-page":"2111","article-title":"Gordon\u2019s syndrome: a sodium-volume-dependent form of hypertension with a genetic basis","author":"Gordon","year":"1995"},{"key":"10.1016\/j.ecl.2011.01.007_bib124","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1542\/peds.69.3.317","article-title":"Severe hypertension, hyperkalemia and renal tubular acidosis responding to dietary sodium restriction","volume":"69","author":"Sanjad","year":"1982","journal-title":"Pediatrics"},{"key":"10.1016\/j.ecl.2011.01.007_bib125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1440-1681.1990.tb01304.x","article-title":"Biochemical correction in the syndrome of hypertension and hyperkalaemia by severe dietary salt restriction suggests renin-aldosterone suppression critical in pathophysiology","volume":"17","author":"Klemm","year":"1990","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ecl.2011.01.007_bib126","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/ki.1981.72","article-title":"Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption","volume":"19","author":"Schambelan","year":"1981","journal-title":"Kidney Int"},{"key":"10.1016\/j.ecl.2011.01.007_bib127","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ajog.2004.07.020","article-title":"Resolution of hypertension during pregnancy in familial hyperkalemia and hypertension with the WNK4Q565E mutation","volume":"192","author":"Mayan","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ecl.2011.01.007_bib128","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng0697-202","article-title":"Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21","volume":"16","author":"Mansfield","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.ecl.2011.01.007_bib129","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/sj.jhh.1000705","article-title":"Linkage of Gordon\u2019s syndrome to the long arm of chromosome 17 in a region recently linked to familial essential hypertension","volume":"12","author":"O\u2019Shaughnessy","year":"1998","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.ecl.2011.01.007_bib130","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/303020","article-title":"A\u00a0new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension","volume":"67","author":"Disse-Nicodeme","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ecl.2011.01.007_bib131","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1126\/science.1062844","article-title":"Human hypertension caused by mutations in WNK kinases","volume":"293","author":"Wilson","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ecl.2011.01.007_bib132","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1681\/ASN.2005030314","article-title":"Familial hyperkalemic hypertension","volume":"17","author":"Hadchouel","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ecl.2011.01.007_bib133","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ng0196-24","article-title":"Gitelman\u2019s variant of Barrter\u2019s syndrome, inherited hypokalemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter","volume":"12","author":"Simon","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.ecl.2011.01.007_bib134","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1210\/jcem.87.7.8449","article-title":"Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density","volume":"87","author":"Mayan","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib135","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1210\/jc.2008-2572","article-title":"Familial hyperkalemia and hypertension: pathogenetic insights based on lithium clearance","volume":"94","author":"Mayan","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.007_bib136","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0022-3476(74)80115-0","article-title":"Hypertension, acidosis, and short stature associated with a defect in renal potassium excretion","volume":"85","author":"Weinstein","year":"1974","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ecl.2011.01.007_bib137","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00852890","article-title":"\u201cChloride-shunt\u201d syndrome: an overlooked cause of renal hypercalciuria","volume":"3","author":"Rodriguez-Soriano","year":"1989","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ecl.2011.01.007_bib138","first-page":"551","article-title":"The syndrome of hypertension and hyperkalemia with normal GFR (Gordon\u2019s syndrome): is there increased proximal sodium reabsorption?","volume":"14","author":"Klemm","year":"1991","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.ecl.2011.01.007_bib139","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/ndt\/gfk029","article-title":"A\u00a0hypothesis linking sodium and lithium reabsorption in the distal nephron","volume":"21","author":"Thomsen","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ecl.2011.01.007_bib140","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/ndt\/gfm641","article-title":"Increased urinary Na-Cl cotransporter protein in familial hyperkalemia and hypertension","volume":"23","author":"Mayan","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ecl.2011.01.007_bib141","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1073\/pnas.242728499","article-title":"WNK1, a kinase mutated in inherited hypertension with hyperkalemia, localizes to diverse Cl- -transporting epithelia","volume":"100","author":"Choate","year":"2003","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ecl.2011.01.007_bib142","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1073\/pnas.0308434100","article-title":"WNK4 regulates apical and basolateral Cl- flux in extrarenal epithelia","volume":"101","author":"Kahle","year":"2004","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ecl.2011.01.007_bib143","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2362.2005.01504.x","article-title":"WNK4 regulates airway Na+ transport: study of familial hyperkalaemia and hypertension","volume":"35","author":"Farfel","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ecl.2011.01.007_bib144","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1056\/NEJM199907153410304","article-title":"Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism","volume":"341","author":"Kerem","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2011.01.007_bib145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2353\/ajpath.2006.051290","article-title":"Cardiovascular expression of the mouse WNK1 gene during development and adulthood revealed by a BAC reporter assay","volume":"169","author":"Delaloy","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ecl.2011.01.007_bib146","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/01.HYP.36.4.477","article-title":"Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study","volume":"36","author":"Levy","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2011.01.007_bib147","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1161\/CIRCULATIONAHA.105.585737","article-title":"Association of blood pressure with genetic variation in\u00a0WNK kinases in a white European population","volume":"112","author":"Zhang","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ecl.2011.01.007_bib148","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1755-5922.2010.00180.x","article-title":"Hypertension, dietary salt intake, and the role of the thiazide-sensitive sodium chloride transporter NCCT","volume":"29","author":"Glover","year":"2011","journal-title":"Cardiovasc Ther"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852911000089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852911000089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:34:39Z","timestamp":1760175279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852911000089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":148,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0889852911000089"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2011.01.007","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Familial or Genetic Primary Aldosteronism and Gordon Syndrome","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2011.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}